Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCP | P55072 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25259657 | 0.89 | — | — | |
| SCHEMBL2238115 | 0.88 | — | — | |
| SCHEMBL9322221 | 0.86 | ERN1 (0.32) | — | |
| SCHEMBL14876922 | 0.84 | — | — | |
| SCHEMBL709843 | 0.80 | — | — | |
| SCHEMBL419449 | 0.78 | VCP (0.38) | VCP | |
| SCHEMBL1809301 | 0.78 | VCP (0.38) | VCP | |
| SCHEMBL1808857 | 0.76 | VCP (0.36) | VCP | |
| SCHEMBL809345 | 0.75 | VCP (0.33) | VCP | |
| SCHEMBL5839348 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6811832-B2 | AGROCHEMICALS, ELECTRONICS, DRUGS | CLARIANT GMBH (DE) | 2004-11-02 | — | — | US | disclosed |
| EP-1153909-B1 | Ortho-substituted benzaldehydes, process for their preparation, and their use | CLARIANT GMBH (DE) | 2004-10-13 | — | — | EP | disclosed |
| US-20010050352-A1 | Agrochemicals, electronics, drugs | CLARIANT GMBH | 2001-12-13 | — | — | US | disclosed |
| EP-1153909-A2 | Ortho-substituted benzaldehydes, process for their preparation, and their use | Clariant GmbH (DE) | 2001-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010050352-A1 | Agrochemicals, electronics, drugs | AFF1, FPR1, CYP2F1 | VCP 3604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.